PMID- 9507016 OWN - NLM STAT- MEDLINE DCOM- 19980416 LR - 20210209 IS - 0021-9258 (Print) IS - 0021-9258 (Linking) VI - 273 IP - 12 DP - 1998 Mar 20 TI - All-trans-retinoic acid inhibits Jun N-terminal kinase-dependent signaling pathways. PG - 7066-71 AB - Retinoids, including retinol and retinoic acid derivatives, inhibit the growth of normal human bronchial epithelial (HBE) cells. The signaling pathways through which retinoids mediate this effect have not been defined. Normal HBE cell growth is stimulated by treatment with a variety of growth factors that increase mitogen-activated protein (MAP) activity. In this study, we examined MAP kinase-dependent pathways as potential targets of retinoid signaling and the role of MAP kinases in retinoid-induced c-fos gene regulation. All-trans-retinoic acid (t-RA) inhibited Jun N-terminal kinase (JNK) and, to a lesser extent, extracellular signal-regulated kinase activity in normal HBE cells. t-RA reduced c-fos mRNA and protein levels by decreasing c-fos gene transcription. The c-fos promoter was activated by co-transfection with a constitutively active JNK kinase (SEK)-1 and suppressed by a dominant negative JNK kinase kinase (MEKK)-1. Furthermore, c-fos expression was inhibited by agonists of retinoic acid receptors (RARs) or retinoid X receptors (RXRs), and suppression of c-fos promoter activity by t-RA was abrogated by treatment with antagonists of RAR-alpha or of all the RXRs. These findings provide the first evidence that t-RA inhibits JNK activity and demonstrate a potential role of JNK-dependent pathways in the suppression of c-fos expression by t-RA. Furthermore, c-fos expression was inhibited through activation of RAR- and RXR-dependent signaling pathways. In light of the growth activation induced by JNK/SEK-dependent pathways in a variety of cells, these data support further investigation into the role of JNK-dependent signaling in the growth-suppressive effects of retinoids. FAU - Lee, H Y AU - Lee HY AD - Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA. FAU - Walsh, G L AU - Walsh GL FAU - Dawson, M I AU - Dawson MI FAU - Hong, W K AU - Hong WK FAU - Kurie, J M AU - Kurie JM LA - eng GR - P50 CA70907/CA/NCI NIH HHS/United States GR - R29 CA67353/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - J Biol Chem JT - The Journal of biological chemistry JID - 2985121R RN - 0 (Receptors, Retinoic Acid) RN - 5688UTC01R (Tretinoin) RN - EC 2.7.11.17 (Calcium-Calmodulin-Dependent Protein Kinases) RN - EC 2.7.11.24 (JNK Mitogen-Activated Protein Kinases) RN - EC 2.7.11.24 (Mitogen-Activated Protein Kinases) SB - IM MH - Bronchi/cytology/drug effects/enzymology MH - Calcium-Calmodulin-Dependent Protein Kinases/*metabolism MH - Cells, Cultured MH - Gene Expression Regulation/drug effects MH - Genes, fos MH - Humans MH - JNK Mitogen-Activated Protein Kinases MH - *Mitogen-Activated Protein Kinases MH - Receptors, Retinoic Acid/*metabolism MH - Signal Transduction/*drug effects MH - Tretinoin/*pharmacology EDAT- 1998/04/18 00:00 MHDA- 1998/04/18 00:01 CRDT- 1998/04/18 00:00 PHST- 1998/04/18 00:00 [pubmed] PHST- 1998/04/18 00:01 [medline] PHST- 1998/04/18 00:00 [entrez] AID - S0021-9258(18)63987-0 [pii] AID - 10.1074/jbc.273.12.7066 [doi] PST - ppublish SO - J Biol Chem. 1998 Mar 20;273(12):7066-71. doi: 10.1074/jbc.273.12.7066.